The T.5 Capacity in Medical Devices Program is a partnership between CCTR and the Tufts Clinical and Translational Science Institute (CTSI) to advance medical device innovation and prototyping. Since 2016, we’ve helped facilitate the critical translation from preclinical development to initial human studies, enabling research teams to turn concepts into testable prototypes and effectively incorporate clinical insights into research and development.
Established in 2008, the Tufts CTSI is one of more than 60 institutions comprising the national CTSA Consortium, led by the National Center for Advancing Translational Sciences. The Tufts CTSI is a robust partnership of more than 40 organizations with nationally recognized strengths in emergency medicine, large effectiveness trials, clinical trials methods innovations, and translational science education. From bench to bedside—and to clinical practice, care delivery, public health, public policy, and beyond, Tufts CTSI is committed to fostering collaboration and innovation across the translational spectrum.